Photon Therapeutics Wins Technology and Innovation Award at AHNTI EU Innovation Showcase 2026
Photon Therapeutics, has been named the winner of the Technology Award at the AHNTI EU Innovation Showcase 2026, recognising its breakthrough approach to advancing animal health innovation.
The award was presented during the AHNTI EU (Animal Health, Nutrition & Technology Innovation) 2026 conference, held at Convene St Paul’s, where a select group of early-stage companies pitched their innovations live in front of an audience of more than 850 industry leaders, investors, pharmaceutical and biotech companies, CDMOs, and strategic partners.
Photon Therapeutics is the company behind the PhotonUVC Vet, a non-contact five second treatment which emits low dose UVC light at a targeted area, deactivating infecting organisms while being safe to host tissues. With corneal infections a leading cause of blindness in humans and pets, the easy-to-use device is simple, safe and effective.
The organisation was selected from a highly competitive cohort of Innovation Showcase finalists, each identified by AHNTI’s prestigious selection committee as a ‘company to watch’ across the sectors of Nutrition, Diagnostics, Biopharma, and Technology.
Mark Leddy, CEO of Photon Therapeutics said:
‘Being recognised with the Innovation and Technology Award at AHNTI EU is an incredible honour. The calibre of innovation presented at the showcase was outstanding, and it’s exciting to be part of an organisation working to redefine the future of animal health through science and technology.’
Jolian Howell, co-founder of Animal Health Angels which has helped Photon Therapeutics raise investment said:
‘The AHA is extremely pleased and proud to have supported Mark and the Photon Therapeutics team in their fundraising journey and send huge congratulations to them all on being AHNTI Showcase Winners’.
The AHNTI Innovation Showcase highlights emerging companies developing solutions that could transform the global animal health landscape. By bringing together innovators with investors and industry leaders, the event creates opportunities for collaboration, partnership and investment that accelerate the path from breakthrough ideas to real-world impact.